Most Popular Investment Trusts Q1

Which closed-end funds have Morningstar.co.uk readers been most interested so far this year as they look for potential SIPP and ISA holdings? 

Szymon Idzikowski 4 April, 2014 | 12:21PM
Facebook Twitter LinkedIn

Investors have been turning to highly rated well known closed-end funds to fill their portfolios over the last three months. The first quarter of the calendar year is known as ISA season – as investors rush to allocate cash into tax-efficient wrappers before the end of the fiscal year.

This ISA season, investors have been researching large, liquid and well-known brands with a solid long-term performance, such as Scottish Mortgage and City of London. Interestingly, some of them had a poor 2013 and yet they remain among the most frequently viewed investment trusts—with Murray International and Personal Assets being an example. That could suggest investment trust buyers are longer-term investors.

But people are willing to take more risk and try to chase returns too, given the biotech fund that has popped up among the top 10 most popular investment trusts on Morningstar.co.uk. We would warn investors however, that this is a sector fund, with a niche specialisation, and should be used with extra caution and play only a niche role in an average investor’s portfolio.

Most Popular Investment Trusts of Q1

Scottish Mortgage Investment Trust (SMT)

Murray International Trust (MYI)

Aberdeen Asian Smaller Companies (AAS)

Finsbury Growth & Income (FGT)

The City of London Investment Trust (CTY)

Personal Assets Trust (PNL)

Temple Bar Investment Trust (TMPL)

The Biotech Growth Trust (BIOG)

Jupiter European Opportunities Trust (JEO)

Aberdeen New Dawn (ABD)

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar
Rating
abrdn Asia Focus plc272.25 GBX1.58Rating
abrdn New Dawn Ord  
Biotech Growth Ord936.00 GBX1.08Rating
City of London Ord408.77 GBX0.43Rating
European Opportunities Trust851.00 GBX1.19Rating
Finsbury Growth & Income Ord820.05 GBX0.74Rating
Murray International Ord250.54 GBX1.02Rating
Personal Assets Ord484.50 GBX0.41Rating
Scottish Mortgage Ord836.40 GBX1.68Rating
Temple Bar Ord259.40 GBX0.93Rating

About Author

Szymon Idzikowski

Szymon Idzikowski  is a closed-end fund analyst with Morningstar.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures